Managed care aspects of managing neurogenic bladder/neurogenic detrusor overactivity.
Neurogenic bladder (NGB) and neurogenic detrusor overactivity (NDO) manifesting in urinary incontinence (UI) can present substantial treatment challenges to clinicians managing patients with underlying neurologic disorders such as multiple sclerosis, Parkinson's disease, spinal cord injury, spina bifida, and stroke. Although the clinical disease burden alone is difficult for patients and those managing their disorders, the significant negative impact that NGB/NDO and UI can have on health-related quality of life and the economic costs surrounding these disorders can be devastating for patients already burdened with neurologic disorders. Careful clinician assessment of these quality-of-life issues and the economic impact of NGB/NDO with UI is needed to appropriately assess the burden these disorders place on patients and their management and to assist clinicians to design the most clinically, socially, and economically effective individualized management plans to optimize patient outcomes.
William_cardarelli@vmed.org.
William J
WJ
Cardarelli
D017281:Cost of Illness; D006296:Health Services / Q000706:statistics & numerical data; D006801:Humans; D008329:Managed Care Programs; D011788:Quality of Life; D014481:United States; D001750:Urinary Bladder, Neurogenic / Q000191:economics* / Q000523:psychology*; D053201:Urinary Bladder, Overactive / Q000191:economics* / Q000523:psychology*